--- title: Oligonucleotide CDMOs in Asia-Pacific path: /modalities/oligonucleotide/apac companies_count: 11 --- # Oligonucleotide CDMOs in Asia-Pacific 11 published CDMOs match Oligonucleotide in Asia-Pacific. Locations in this set include United States, China, United Kingdom, India, Japan, and Singapore. Capabilities that show up most often in this set: CMC Analytical Development, Oligonucleotide Manufacturing, Process Development, API Synthesis & Manufacturing, and Peptide Manufacturing. ## Matching companies - [Ajinomoto Bio-Pharma Services](/companies/ajibio-pharma) - Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Bachem](/companies/bachem) - Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale. - [Global Biotech Laboratories](/companies/globalbiotechlaboratories) - Global Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents. - [HitGen Inc.](/companies/hitgen) - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally. - [PharmaBlock](/companies/pharmablock) - Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Porton](/companies/portonpharma) - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies. - [Sapala Organics](/companies/sapalaorganics) - Custom synthesis of nucleic acid building blocks, modified phosphoramidites and oligonucleotide delivery compounds, plus FTE-based CRO and fee-for-service CDMO engagements. Orthogonal analytical services serve clients from early R&D through pharma innovators. - [Stevanato Group](/companies/stevanatogroup) - Leading global provider of integrated drug containment, drug delivery, and diagnostic solutions with 75+ years' experience in glass primary packaging, contract manufacturing, and analytical services across development, clinical, and commercial stages. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.